Abstract Stanniocalcin 2 (STC2) is a glycoprotein which is expressed in a broad spectrum of
tumour cells and tumour tissues derived from human breast, colorectum, stomach …

Radioresistance is the major reason for the failure of radiotherapy in esophageal squamous
cell carcinoma (ESCC). Previous evidence indicated that stanniocalcin 2 (STC2) participates …

ABSTRACT Human stanniocalcin 2 (STC2) is an ortholog of fish stanniocalcins (STCs) and
is widely expressed in various organs and tissues. The gene is localized on chromosome …

Constitutive activation of the epidermal growth factor receptor (EGFR) signaling pathway is
implicated in the initiation and progression of lung cancer. EGFR tyrosine kinase inhibitor …

Background. To date, 4 classes of histone deacetylases (HDACs) have been identified in
humans. Class I HDACs are zinc-dependent and NAD+-independent enzymes, and include …

Abstract Stanniocalcin 2 (STC2), a secretory glycoprotein hormone, regulates many
biological processes including cell proliferation, apoptosis, tumorigenesis and …

Background: Neoadjuvant chemoradiotherapy (NCRT) for advanced rectal cancer (RC) is a
well-evidenced therapy; however, some RC patients have no therapeutic response. Patient …

Background Antipsychotic (AP) medications are the first line of treatment for schizophrenia.
However, most conferr a risk of antipsychotic-induced weight gain (AIWG). The objective of …

Multidrug resistance (MDR) limits the anticancer effects of chemotherapy in patients with
metastatic colorectal cancer (CRC). Oxaliplatin is a common component of combinational …

Aberrant expression of gene is driven by its promoter methylation and is the key molecular
basis of carcinogenic processes. This study aimed at identifying a risk signature of …